For an appropriate candidate for intrathecal drug delivery, what kind of protocol is typically followed for a screening test?
There are a number of viable options to choose from when conducting a screening test for intrathecal drug delivery. The specific protocol that is selected depends on the physician’s preference but may be influenced by the requirements of insurers or hospital protocol. The screening test can be performed epidurally or intrathecally. A screening dose can be administered as a bolus dose or continuous flow through a percutaneous catheter (that may be tunneled). The length of the screening test can vary. The screening test can be performed on an inpatient or outpatient basis. The patient’s pathology and the goals of treatment often influence the type of screening protocol. For example, a cancer patient might be considered for a short trial, perhaps even a single shot, whereas a patient in whom improved function is a major goal of therapy might warrant a prolonged trial with objective assessment. Epidural fibrosis or metastases would argue for intrathecal rather than an epidural trial. If re
Related Questions
- In the patient who fails a screening test with neurostimulation, when would you consider a screening test for intrathecal drug delivery?
- For an appropriate candidate for intrathecal drug delivery, what kind of protocol is typically followed for a screening test?
- How will my doctor know if I am a candidate for intrathecal drug delivery?
